Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF) Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting
IJC HEART & VASCULATURE. Bd. 35. 2021
Erscheinungsjahr: 2021
Publikationstyp: Zeitschriftenaufsatz
| Geprüft | Bibliothek |
Autoren
Riesinger, Lisa (Autor)
Strobl, Claudia (Autor)
Leistner, David M. (Autor)
Gori, Tommaso (Autor)
Akin, Ibrahim (Autor)
Mehr, Michael (Autor)
Kellnar, Antonia (Autor)
Mahabadi, Amir A. (Autor)
Bogossian, Harilaos (Autor)
Block, Michael (Autor)
Edelmann, Frank (Autor)
Sarafoff, Nikolaus (Autor)
Sibbing, Dirk (Autor)
Ince, Hueseyin (Autor)
Rassaf, Tienush (Autor)
Mansmann, Ulrich (Autor)
Mehilli, Julinda (Autor)
Kaeaeb, Stefan (Autor)
Hausleiter, Joerg (Autor)
Massberg, Steffen (Autor)
Wakili, Reza (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
